These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12383477)
1. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer. Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477 [TBL] [Abstract][Full Text] [Related]
2. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors. Zhao R; Xu G; Yue B; Liebich HM; Zhang Y J Chromatogr A; 1998 Dec; 828(1-2):489-96. PubMed ID: 9916327 [TBL] [Abstract][Full Text] [Related]
3. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides. Seidel P; Seidel A; Herbarth O Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256 [TBL] [Abstract][Full Text] [Related]
5. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264 [TBL] [Abstract][Full Text] [Related]
6. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations. Seidel A; Seidel P; Manuwald O; Herbarth O Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography]. Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995 [TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341 [TBL] [Abstract][Full Text] [Related]
9. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients. Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352 [TBL] [Abstract][Full Text] [Related]
10. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453 [TBL] [Abstract][Full Text] [Related]
11. Urinary nucleosides as biological markers for patients with colorectal cancer. Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285 [TBL] [Abstract][Full Text] [Related]
12. Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum. McEntire JE; Kuo KC; Smith ME; Stalling DL; Richens JW; Zumwalt RW; Gehrke CW; Papermaster BW Cancer Res; 1989 Feb; 49(4):1057-62. PubMed ID: 2912551 [TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers. Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127 [TBL] [Abstract][Full Text] [Related]
15. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique. Struck-Lewicka W; Kaliszan R; Markuszewski MJ J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632 [TBL] [Abstract][Full Text] [Related]
16. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356 [No Abstract] [Full Text] [Related]
17. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489 [TBL] [Abstract][Full Text] [Related]
18. A new way to fast and high resolution determination of modified nucleosides. Studzińska S; Buszewski B J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():93-101. PubMed ID: 22309775 [TBL] [Abstract][Full Text] [Related]
19. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357 [TBL] [Abstract][Full Text] [Related]
20. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer]. Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]